Looking at the supplement industry as a barometer for drug delivery systems, it’s apparent that gummies are gaining traction as a preferred delivery system. In 2019, the sales of non-pill formats, including gummies, powders and shots, exceeded the sales of pill formats and that gap between the pill and non-pill market share continues to grow. In 2021, non-pill delivery formats represented 60.8% of sales.

Gummies are now the single largest format by market share (although the total for combined pills, softgels, capsules and pill packs is still greater), and represent $12.97 billion in annual sales. The popularity of gummies will likely continue to grow as, according to Nutrition Business Journal, supplement consumers in 2021 chose non-pill formats for 60% of their purchases while the demand for tablets and capsules are flat to down and soft gels, on the supplement side, are also flat.

Download Avéma’s White Paper to learn how the company is leveraging its decades of formulation experience with our new starchless gummy manufacturing capabilities.